Hansa Biopharma AB (HNSA) — Financial Flexibility Index
Hansa Biopharma AB (HNSA) has a Financial Flexibility Index of -0.09x as of June 2025. Free cash flow of Skr-111.70 Million (operating CF Skr-111.70 Million minus capex Skr0.00) represents 0% of total liabilities (Skr1.28 Billion). Also explore HNSA shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hansa Biopharma AB Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Hansa Biopharma AB across 17 annual periods. Check HNSA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hansa Biopharma AB (2008–2024)
Year-by-year free cash flow to debt coverage for Hansa Biopharma AB. For the full company profile including market capitalisation, see HNSA company net worth.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.49x | Skr-674.77 Million | Skr-674.88 Million | Skr1.39 Billion | ▲ +23.8% |
| 2023 | -0.64x | Skr-755.37 Million | Skr-755.65 Million | Skr1.19 Billion | ▼ -38.3% |
| 2022 | -0.46x | Skr-499.40 Million | Skr-502.73 Million | Skr1.08 Billion | ▲ +75.5% |
| 2021 | -1.88x | Skr-478.77 Million | Skr-481.17 Million | Skr255.24 Million | ▼ -24.4% |
| 2020 | -1.51x | Skr-289.98 Million | Skr-290.27 Million | Skr192.37 Million | ▲ +53.9% |
| 2019 | -3.27x | Skr-331.35 Million | Skr-334.77 Million | Skr101.42 Million | ▼ -37.3% |
| 2018 | -2.38x | Skr-202.07 Million | Skr-204.56 Million | Skr84.94 Million | ▲ +19.9% |
| 2017 | -2.97x | Skr-147.70 Million | Skr-150.10 Million | Skr49.75 Million | ▲ +14.4% |
| 2016 | -3.47x | Skr-93.58 Million | Skr-94.56 Million | Skr26.98 Million | ▲ +22.9% |
| 2015 | -4.50x | Skr-56.48 Million | Skr-57.80 Million | Skr12.56 Million | ▲ +9.6% |
| 2014 | -4.97x | Skr-22.42 Million | Skr-23.62 Million | Skr4.51 Million | ▼ -71.3% |
| 2013 | -2.90x | Skr-14.80 Million | Skr-14.87 Million | Skr5.10 Million | ▲ +58.6% |
| 2012 | -7.01x | Skr-17.93 Million | Skr-20.63 Million | Skr2.56 Million | ▼ -59.9% |
| 2011 | -4.39x | Skr-27.14 Million | Skr-27.14 Million | Skr6.19 Million | ▼ -36.6% |
| 2010 | -3.21x | Skr-18.09 Million | Skr-18.09 Million | Skr5.64 Million | ▼ -208.2% |
| 2009 | -1.04x | Skr-13.78 Million | Skr-13.79 Million | Skr13.23 Million | ▲ +63.0% |
| 2008 | -2.82x | Skr-11.64 Million | Skr-15.58 Million | Skr4.13 Million | — |